Brief: Tarsus Pharmaceuticals Q1 Net Income USD -25.12 Million Vs. IBES Estimate USD -25.1 Million
01/05/2025 21:05
May 01 (Reuters) - Tarsus Pharmaceuticals Q1 basic EPS USD -0.64.
Recent news on Tarsus Pharmaceuticals
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Tarsus Pharmaceuticals Files For Offering Of Up To 2.91 Million Shares Of Common Stock By Selling Stockholders
U.S. RESEARCH ROUNDUP-Argan, Mastec, Oracle
Tarsus Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition (updated)